Archived Newsletters

21. 06.16.22 -- Formulating Complex Molecules Using Advanced Technologies 6/16/2022

    06/16/22 Outsourced Pharma Newsletter

22. 06.15.22 -- Rethink Genome Editing of CAR T Cells: From Discovery to Scale-Up 6/15/2022

    06/15/22 Outsourced Pharma Newsletter

23. 06.15.22 -- Breaking Down The CDMO Size Barrier 6/15/2022
    06/15/22 Outsourced Pharma Newsletter
24. 06.14.22 -- Accelerate Biologics Development With Strategic CDMO Partnerships 6/14/2022

    06/14/22 Outsourced Pharma Newsletter

25. 06.13.22 -- Process Development: The Rodney Dangerfield Of Outsourcing? 6/13/2022
    06/13/22 Outsourced Pharma Newsletter
26. 06.11.22 -- A Carrier-Free Option For Highly Dispersed API Delivery 6/11/2022

    06/11/22 Outsourced Pharma Newsletter

27. 06.10.22 -- De-Risking Combination Product Development For Biosimilars 6/10/2022

    06/10/22 Outsourced Pharma Newsletter

28. 06.09.22 -- Manufacturing Strategies For Advanced Therapeutics 6/9/2022
    06/09/22 Outsourced Pharma Newsletter
29. 06.09.22 -- Mechanistic Chromatography Modeling For Smarter Process Development 6/9/2022

    06/09/22 Outsourced Pharma Newsletter

30. 06.08.22 -- New Episodes for You: Live Biologics & The Microbiome, Inside CAR-T Therapy for Ovarian Cancer and more. 6/8/2022
    06/08/22 Outsourced Pharma Newsletter